(RTTNews) - Teva Pharmaceuticals USA is recalling specific lots of various strengths of FENTANYL Buccal Tablets CII to the consumer level citing a labeling error, the U.S. Food and Drug Administration ...

ORAVIG (miconazole) 50mg buccal tablets by Strativa The FDA has approved Oravig (miconazole buccal tablets, from Strativa) for the treatment of oropharyngeal candidiasis (OPC) in patients ≥16 years of ...

First and Only Local, Oral Prescription Formulation of Miconazole Approved for Thrush in the United States WOODCLIFF LAKE, N.J., April 16, 2010 /PRNewswire via COMTEX/ --Strativa Pharmaceuticals today ...

HONOLULU, HI—Patientswith chronic, noncancer-related pain who received fentanyl buccal tablet had consistent short-term efficacy acrossclinically meaningful analgesia measures, according to results of ...

Dara BioSciences ($DARA) is the new marketer of the only orally dissolving buccal tablet approved for oral thrush, which occurs when the Candida albicans fungus grows ...

The FDA has approved Oravig (miconazole) buccal tablets for the treatment of oropharyngeal candidiasis in adults and childen aged 16 years and older. The drug is the first and only local, oral ...

A labeling problem has forced Teva to recall 13 lots of fentanyl buccal tablets. Safety updates on the product insert were omitted, leaving the possibility of misuse that “could lead to ...

Teva Pharmaceuticals USA, has initiated a voluntary nationwide recall of specific lots of various strengths of FENTANYL Buccal Tablets CII to the Consumer Level. Teva USA manufactured and labeled ...

Background and objectives: Patients with cancer, particularly those undergoing chemotherapy or radiotherapy, may develop oral mucositis. This is the first study to investigate the absorption profile ...

This phase I, multicentre, open-label study was conducted in the US between April and September 2005. The two participating centres obtained Institutional Review Board approval and all patients ...